We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biosphere Medical (MM) | NASDAQ:BSMD | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.38 | 0 | 01:00:00 |
SECURITIES AND EXCHANGE COMMISSION
|
Washington, D. C. 20549
|
SCHEDULE l3D
|
Under the Securities Exchange Act of 1934
|
(Amendment No. 5)*
|
BIOSPHERE MEDICAL, INC.
|
(Name of Issuer)
|
Common Stock, par value $0.01 per share
|
(Title of Class of Securities)
|
09066V 10 3
|
(CUSIP Number)
|
with a copy to:
|
|||
Mr. Stephen Feinberg
|
Robert G. Minion, Esq.
|
||
c/o Cerberus Capital Management, L.P.
|
Lowenstein Sandler PC
|
||
299 Park Avenue
|
1251 Avenue of the Americas, 18th Floor
|
||
22nd Floor
|
New York, NY 10020
|
||
New York, New York 10171
|
(973) 597-2424
|
||
(212) 891-2100
|
(Name, Address and Telephone Number of Persons
|
Authorized to Receive Notices and Communications)
|
September 10, 2010
|
(Date of Event which Requires Filing of this Statement)
|
If the filing person has previously filed a statement on Schedule l3G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]
|
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7(b) for other parties to whom copies are to be sent.
|
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
Cusip No. 09066V 10 3
|
1)
|
Names of Reporting Persons/I.R.S. Identification Nos. of
|
||||
Above Persons (entities only):
|
|||||
Stephen Feinberg |
2)
|
Check the Appropriate Box if a Member of a Group (See Instructions):
|
|
(a)
|
Not
|
|
(b)
|
Applicable
|
3)
|
SEC Use Only
|
||
4)
|
Source of Funds (See Instructions): WC
|
||
5)
|
Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e):
|
||
Not Applicable |
6)
|
Citizenship or Place of Organization: United States
|
Number of
|
7)
|
Sole Voting Power:
|
0*
|
||
Shares Beneficially
|
8)
|
Shared Voting Power:
|
*
|
||
Owned by
|
|||||
Each Reporting
|
9)
|
Sole Dispositive Power:
|
0*
|
||
Person With:
|
10)
|
Shared Dispositive Power:
|
*
|
11)
|
Aggregate Amount Beneficially Owned by Each Reporting Person:
|
0*
|
||
12)
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions):
|
|||
Not Applicable
|
13)
|
Percent of Class Represented by Amount in Row (11):
|
0%*
|
14)
|
Type of Reporting Person (See Instructions):
|
IA, IN
|
September 14, 2010
|
||
/s/ Stephen Feinberg
|
||
Stephen Feinberg, individually and in his capacity as a senior managing director of Cerberus Associates, L.L.C., the general partner of Cerberus Partners, L.P., and as a senior managing director of Partridge Hill Overseas Management, LLC, the investment manager of Cerberus International, Ltd.
|
1 Year Biosphere Medical (MM) Chart |
1 Month Biosphere Medical (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions